E
Arrowhead Pharmaceuticals, Inc. ARWR
$21.33 $0.582.80% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -175.24M 370.45M -173.09M -170.54M -170.79M
Total Depreciation and Amortization 6.22M 6.08M 5.24M 5.03M 4.78M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 32.26M 38.00M 29.02M 20.34M 25.95M
Change in Net Operating Assets -17.96M 45.53M -7.44M 7.95M 24.64M
Cash from Operations -154.72M 460.05M -146.27M -137.22M -115.42M
Capital Expenditure -2.36M -5.30M -7.52M -24.29M -14.45M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 143.75M -414.92M 84.43M -198.63M 21.40M
Cash from Investing 141.39M -420.21M 76.91M -222.92M 6.95M
Total Debt Issued 7.10M -- -- 392.00M --
Total Debt Repaid -50.00M -151.63M -- -- --
Issuance of Common Stock 223.00K 244.01M 634.00K 223.00K 387.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 0.00 0.00 20.00M -3.13M 50.00M
Cash from Financing -42.68M 92.38M 20.63M 389.09M 50.39M
Foreign Exchange rate Adjustments 93.00K -402.00K -68.00K 4.34M -223.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -55.92M 131.82M -48.80M 33.29M -58.31M